Singapore: Biofourmis raises $5m Series A from NSI Ventures, Aviva Ventures Shiwen Yap December 11, 2017 PremiumSingapore-based health analytics platform Biofourmis has closed a $5-million Series A round from NSI Ventures and Aviva Ventures, in addition to securing a partnership with US-based Mayo Clinic. Continue reading this story with a subscription to DealStreetAsia. Subscribe Already a subscriber? Log in Should your colleagues be reading this article too? Contact us for corporate subscriptions at email@example.com.